Nadine Lamare
Overview
    Explore the profile of Nadine Lamare including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              4
            
            
              Citations
              42
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Mpoudi-Etame M, Tovar Sanchez T, Bousmah M, Omgba Bassega P, Olinga J, Mimbe E, et al.
  
  
    Open Forum Infect Dis
    . 2023 Dec;
          10(12):ofad582.
    
    PMID: 38156046
  
  
          Background: A prospective study was extended to the new antiretroviral and monitoring strategies in HIV-infected adults in low-income countries (NAMSAL-ANRS)-12313 trial, a 96-week open-label, multicenter, randomized phase 3 trial comparing...
      
2.
        
    
    Ndongo F, Guichet E, Mimbe E, Ndie J, Pelloquin R, Varloteaux M, et al.
  
  
    Emerg Infect Dis
    . 2022 Apr;
          28(6):1233-1236.
    
    PMID: 35470795
  
  
          We conducted 2 independent population-based SARS-CoV-2 serosurveys in Yaoundé, Cameroon, during January 27-February 6 and April 24-May 19, 2021. Overall age-standardized SARS-CoV-2 IgG seroprevalence increased from 18.6% in the first...
      
3.
        
    
    Tchouwa G, Eymard-Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, et al.
  
  
    EClinicalMedicine
    . 2019 Jun;
          1:21-27.
    
    PMID: 31193678
  
  
          Background: Population-based studies to estimate viral load (VL) suppression and rate of acquired HIV drug resistance (ADR) are essential in sub-Saharan Africa. We conducted the first nationally representative study estimating...
      
4.
        
    
    Tchouwa G, Eymard-Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, et al.
  
  
    J Antimicrob Chemother
    . 2018 Jun;
          73(9):2468-2474.
    
    PMID: 29931063
  
  
          Background: Pretreatment HIV drug resistance (PDR) has the potential to affect treatment outcome and mortality. We present here the first nationally representative PDR study conducted in Cameroon. Methods: From February...